China Intravenous-to-Subcutaneous Drug Industry 2017 Market Research Report

 Table of Contents

China Intravenous-to-Subcutaneous Drug Market Research Report 2017
1 Intravenous-to-Subcutaneous Drug Market Overview
    1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
    1.2 Intravenous-to-Subcutaneous Drug Segment by Type
        1.2.1 China Production Market Share of Intravenous-to-Subcutaneous Drug Type in 2015
        1.2.2 Type I
        1.2.3 Type II
    1.3 Applications of Intravenous-to-Subcutaneous Drug
        1.3.1 Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
    1.4 China Market Size (Value) of Intravenous-to-Subcutaneous Drug (2012-2022)
    1.5 China Intravenous-to-Subcutaneous Drug Status and Outlook
    1.6 Government Policies

2 China Intravenous-to-Subcutaneous Drug Market Competition by Manufacturers
    2.1 China Intravenous-to-Subcutaneous Drug Capacity, Production and Share by Manufacturers (2015 and 2016)
    2.2 China Intravenous-to-Subcutaneous Drug Revenue and Share by Manufacturers (2015 and 2016)
    2.3 China Intravenous-to-Subcutaneous Drug Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Intravenous-to-Subcutaneous Drug Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Intravenous-to-Subcutaneous Drug Market Competitive Situation and Trends
        2.5.1 Intravenous-to-Subcutaneous Drug Market Concentration Rate
        2.5.2 Intravenous-to-Subcutaneous Drug Market Share of Top 3 and Top 5 Manufacturers

3 China Intravenous-to-Subcutaneous Drug Manufacturers Profiles/Analysis
    3.1 Baxter
        3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.1.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.1.2.1 Product A
            3.1.2.2 Product B
        3.1.3 Baxter Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.1.4 Main Business/Business Overview
    3.2 Britannia
        3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.2.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.2.2.1 Product A
            3.2.2.2 Product B
        3.2.3 Britannia Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.2.4 Main Business/Business Overview
    3.3 Capricor
        3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.3.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.3.2.1 Product A
            3.3.2.2 Product B
        3.3.3 Capricor Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.3.4 Main Business/Business Overview
    3.4 CSL Behring
        3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.4.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.4.2.1 Product A
            3.4.2.2 Product B
        3.4.3 CSL Behring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.4.4 Main Business/Business Overview
    3.5 GlaxoSmithKline
        3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.5.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.5.2.1 Product A
            3.5.2.2 Product B
        3.5.3 GlaxoSmithKline Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.5.4 Main Business/Business Overview
    3.6 Grifols
        3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.6.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.6.2.1 Product A
            3.6.2.2 Product B
        3.6.3 Grifols Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.6.4 Main Business/Business Overview
    3.7 Ferring
        3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.7.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.7.2.1 Product A
            3.7.2.2 Product B
        3.7.3 Ferring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.7.4 Main Business/Business Overview
    3.8 Janssen
        3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.8.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
            3.8.2.1 Product A
            3.8.2.2 Product B
        3.8.3 Janssen Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.8.4 Main Business/Business Overview

4 China Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
    4.1 China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth (2012-2017)
    4.2 China Intravenous-to-Subcutaneous Drug Revenue and Growth (2012-2017)
    4.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)

5 China Intravenous-to-Subcutaneous Drug Production, Revenue (Value), Price Trend by Type
    5.1 China Intravenous-to-Subcutaneous Drug Production and Market Share by Type (2012-2017)
    5.2 China Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
    5.3 China Intravenous-to-Subcutaneous Drug Price by Type (2012-2017)
    5.4 China Intravenous-to-Subcutaneous Drug Production Growth by Type (2012-2017)

6 China Intravenous-to-Subcutaneous Drug Market Analysis by Application
    6.1 China Intravenous-to-Subcutaneous Drug Consumption and Market Share by Application (2012-2017)
    6.2 China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Application
        6.3.2 Emerging Markets/Countries

7 ChinaIntravenous-to-Subcutaneous Drug Market Analysis by Regions (Provinces)
    7.1 China Intravenous-to-Subcutaneous Drug Production, Production Value and Price by Regions (Provinces)(2012-2017)
        7.1.1 China Intravenous-to-Subcutaneous Drug Production and Market Share by Regions (Provinces)(2012-2017)
        7.1.2 China Intravenous-to-Subcutaneous Drug Production Value and Market Share by Regions (Provinces)(2012-2017)
        7.1.3 China Intravenous-to-Subcutaneous Drug Sales Price by Regions (Provinces)(2012-2017)
    7.2 China Intravenous-to-Subcutaneous Drug Consumption by Regions (Provinces)(2012-2017)
    7.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)

8 Intravenous-to-Subcutaneous Drug Manufacturing Cost Analysis
    8.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 China Intravenous-to-Subcutaneous Drug Market Forecast (2017-2022)
    12.1 China Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue Forecast (2017-2022)
    12.2 China Intravenous-to-Subcutaneous Drug Production, Import, Export and Consumption Forecast (2017-2022)
    12.3 China Intravenous-to-Subcutaneous Drug Production Forecast by Type (2017-2022)
    12.4 China Intravenous-to-Subcutaneous Drug Consumption Forecast by Application (2017-2022)
    12.5 China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
        12.5.1 China Intravenous-to-Subcutaneous Drug Production Forecast by Regions (Provinces)(2017-2022)
        12.5.2 China Intravenous-to-Subcutaneous Drug Consumption Forecast by Regions (Provinces)(2017-2022)
        12.5.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
    12.6 Intravenous-to-Subcutaneous Drug Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures 

    Figure Picture of Intravenous-to-Subcutaneous Drug
    Figure China Production Market Share of Intravenous-to-Subcutaneous Drug by Type in 2015
    Figure Product Picture of Type I
    Table Major Manufacturers of Type I
    Figure Product Picture of Type II
    Table Major Manufacturers of Type II
    Table Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
    Figure Application 1 Examples
    Figure Application 2 Examples
    Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Table China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers (2015 and 2016)
    Table China Intravenous-to-Subcutaneous Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
    Figure China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers in 2015
    Figure China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers in 2016
    Table China Intravenous-to-Subcutaneous Drug Production of Key Manufacturers (2015 and 2016)
    Table China Intravenous-to-Subcutaneous Drug Production Share by Manufacturers (2015 and 2016)
    Figure 2015 Intravenous-to-Subcutaneous Drug Production Share by Manufacturers
    Figure 2016 Intravenous-to-Subcutaneous Drug Production Share by Manufacturers
    Table China Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
    Table China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
    Table 2016 China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
    Table China Market Intravenous-to-Subcutaneous Drug Average Price of Key Manufacturers (2015 and 2016)
    Figure China Market Intravenous-to-Subcutaneous Drug Average Price of Key Manufacturers in 2015
    Table Manufacturers Intravenous-to-Subcutaneous Drug Manufacturing Base Distribution and Sales Area
    Table Manufacturers Intravenous-to-Subcutaneous Drug Product Type
    Figure Intravenous-to-Subcutaneous Drug Market Share of Top 3 Manufacturers
    Figure Intravenous-to-Subcutaneous Drug Market Share of Top 5 Manufacturers
    Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Baxter Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Baxter Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table Britannia Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Britannia Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Britannia Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table Capricor Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Capricor Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Capricor Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table CSL Behring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure CSL Behring Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table GlaxoSmithKline Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure GlaxoSmithKline Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Grifols Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Grifols Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table Ferring Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Ferring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Ferring Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Table Janssen Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Janssen Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Janssen Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
    Figure China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth (2012-2017)
    Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production by Type (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production Share by Type (2012-2017)
    Figure Production Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
    Figure 2015 Production Market Share of Intravenous-to-Subcutaneous Drug by Type
    Table China Intravenous-to-Subcutaneous Drug Revenue by Type (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Revenue Share by Type (2012-2017)
    Figure Production Revenue Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
    Figure 2015 Revenue Market Share of Intravenous-to-Subcutaneous Drug by Type
    Table China Intravenous-to-Subcutaneous Drug Price by Type (2012-2017)
    Figure China Intravenous-to-Subcutaneous Drug Production Growth by Type (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Consumption by Application (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Consumption Market Share by Application (2012-2017)
    Figure China Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
    Table China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
    Figure China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production Market Share by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production Value by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production Value Market Share by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Sales Price by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Consumption by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Consumption Market Share by Regions (Provinces)(2012-2017)
    Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Intravenous-to-Subcutaneous Drug
    Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
    Figure Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
    Table Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
    Table Major Buyers of Intravenous-to-Subcutaneous Drug
    Table Distributors/Traders List
    Figure China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth Rate Forecast (2017-2022)
    Figure China Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Production, Import, Export and Consumption Forecast (2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Production Forecast by Type (2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Consumption Forecast by Application (2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Production Forecast by Regions (Provinces)(2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Consumption Forecast by Regions (Provinces)(2017-2022)
    Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy